Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case-control study
Please cite this paper as: Wilailak S, Vipupinyo C, Suraseranivong V, Chotivanich K, Kietpeerakool C, Tanapat Y, Therasakvichya S, Hamontri S, Linasmita V, Bunyapipat S, Chindavijak S, Ittiwisavakul K, Khemapech N, Suekwattana P, Thanapprapasr D, Lumbiganon P. Depot medroxyprogesterone acetate and e...
Saved in:
| Published in: | BJOG : an international journal of obstetrics and gynaecology Vol. 119; no. 6; pp. 672 - 677 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Oxford, UK
Blackwell Publishing Ltd
01-05-2012
Blackwell |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Please cite this paper as: Wilailak S, Vipupinyo C, Suraseranivong V, Chotivanich K, Kietpeerakool C, Tanapat Y, Therasakvichya S, Hamontri S, Linasmita V, Bunyapipat S, Chindavijak S, Ittiwisavakul K, Khemapech N, Suekwattana P, Thanapprapasr D, Lumbiganon P. Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case–control study. BJOG 2012;119:672–677.
Objective To evaluate the effect of depot medroxyprogesterone acetate (DMPA) in protecting against epithelial ovarian cancer (EOC) and to evaluate factors associated with the risk of EOC.
Design A multicentre, case–control study.
Setting Twelve hospitals located across Thailand.
Population Three hundred and thirty patients with EOC (‘cases’) and 982 matched controls were recruited from the 12 hospitals. Cases were newly diagnosed patients with EOC, demonstrated pathologically. Controls were age‐matched patients admitted to different wards in the same hospital.
Methods Cases and controls were interviewed by trained interviewers using a standardised pre‐tested questionnaire. The factors associated with EOC were evaluated using univariate and multivariate analyses.
Main outcome measures The odds ratio (OR) and 95% confidence interval (95% CI) were calculated to assess the relationship between DMPA and EOC.
Results The use of DMPA was found to be associated with a 39% reduction in the risk of EOC with an OR of 0.61 and a 95% CI of 0.44–0.85 (P = 0.002). A significant risk reduction (83%) was observed when the duration of DMPA use was >3 years (OR 0.17; 95% CI 0.07–0.39; P < 0.001). Other factors associated with a reduced risk of EOC were the use of combined oral contraceptive pills and breastfeeding. A factor associated with an increased risk of EOC was a family history of gynaecological cancer.
Conclusions The results suggest that DMPA may have a protective effect against EOC. If this effect is real, then it represents an important non‐contraceptive benefit of DMPA. |
|---|---|
| AbstractList | Please cite this paper as:
Wilailak S, Vipupinyo C, Suraseranivong V, Chotivanich K, Kietpeerakool C, Tanapat Y, Therasakvichya S, Hamontri S, Linasmita V, Bunyapipat S, Chindavijak S, Ittiwisavakul K, Khemapech N, Suekwattana P, Thanapprapasr D, Lumbiganon P. Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case–control study. BJOG 2012;119:672–677.
Objective
To evaluate the effect of depot medroxyprogesterone acetate (DMPA) in protecting against epithelial ovarian cancer (EOC) and to evaluate factors associated with the risk of EOC.
Design
A multicentre, case–control study.
Setting
Twelve hospitals located across Thailand.
Population
Three hundred and thirty patients with EOC (‘cases’) and 982 matched controls were recruited from the 12 hospitals. Cases were newly diagnosed patients with EOC, demonstrated pathologically. Controls were age‐matched patients admitted to different wards in the same hospital.
Methods
Cases and controls were interviewed by trained interviewers using a standardised pre‐tested questionnaire. The factors associated with EOC were evaluated using univariate and multivariate analyses.
Main outcome measures
The odds ratio (OR) and 95% confidence interval (95% CI) were calculated to assess the relationship between DMPA and EOC.
Results
The use of DMPA was found to be associated with a 39% reduction in the risk of EOC with an OR of 0.61 and a 95% CI of 0.44–0.85 (
P
= 0.002). A significant risk reduction (83%) was observed when the duration of DMPA use was >3 years (OR 0.17; 95% CI 0.07–0.39;
P
< 0.001). Other factors associated with a reduced risk of EOC were the use of combined oral contraceptive pills and breastfeeding. A factor associated with an increased risk of EOC was a family history of gynaecological cancer.
Conclusions
The results suggest that DMPA may have a protective effect against EOC. If this effect is real, then it represents an important non‐contraceptive benefit of DMPA. OBJECTIVETo evaluate the effect of depot medroxyprogesterone acetate (DMPA) in protecting against epithelial ovarian cancer (EOC) and to evaluate factors associated with the risk of EOC.DESIGNA multicentre, case-control study.SETTINGTwelve hospitals located across Thailand.POPULATIONThree hundred and thirty patients with EOC ('cases') and 982 matched controls were recruited from the 12 hospitals. Cases were newly diagnosed patients with EOC, demonstrated pathologically. Controls were age-matched patients admitted to different wards in the same hospital.METHODSCases and controls were interviewed by trained interviewers using a standardised pre-tested questionnaire. The factors associated with EOC were evaluated using univariate and multivariate analyses.MAIN OUTCOME MEASURESThe odds ratio (OR) and 95% confidence interval (95% CI) were calculated to assess the relationship between DMPA and EOC.RESULTSThe use of DMPA was found to be associated with a 39% reduction in the risk of EOC with an OR of 0.61 and a 95% CI of 0.44-0.85 (P = 0.002). A significant risk reduction (83%) was observed when the duration of DMPA use was >3 years (OR 0.17; 95% CI 0.07-0.39; P < 0.001). Other factors associated with a reduced risk of EOC were the use of combined oral contraceptive pills and breastfeeding. A factor associated with an increased risk of EOC was a family history of gynaecological cancer.CONCLUSIONSThe results suggest that DMPA may have a protective effect against EOC. If this effect is real, then it represents an important non-contraceptive benefit of DMPA. Please cite this paper as: Wilailak S, Vipupinyo C, Suraseranivong V, Chotivanich K, Kietpeerakool C, Tanapat Y, Therasakvichya S, Hamontri S, Linasmita V, Bunyapipat S, Chindavijak S, Ittiwisavakul K, Khemapech N, Suekwattana P, Thanapprapasr D, Lumbiganon P. Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case–control study. BJOG 2012;119:672–677. Objective To evaluate the effect of depot medroxyprogesterone acetate (DMPA) in protecting against epithelial ovarian cancer (EOC) and to evaluate factors associated with the risk of EOC. Design A multicentre, case–control study. Setting Twelve hospitals located across Thailand. Population Three hundred and thirty patients with EOC (‘cases’) and 982 matched controls were recruited from the 12 hospitals. Cases were newly diagnosed patients with EOC, demonstrated pathologically. Controls were age‐matched patients admitted to different wards in the same hospital. Methods Cases and controls were interviewed by trained interviewers using a standardised pre‐tested questionnaire. The factors associated with EOC were evaluated using univariate and multivariate analyses. Main outcome measures The odds ratio (OR) and 95% confidence interval (95% CI) were calculated to assess the relationship between DMPA and EOC. Results The use of DMPA was found to be associated with a 39% reduction in the risk of EOC with an OR of 0.61 and a 95% CI of 0.44–0.85 (P = 0.002). A significant risk reduction (83%) was observed when the duration of DMPA use was >3 years (OR 0.17; 95% CI 0.07–0.39; P < 0.001). Other factors associated with a reduced risk of EOC were the use of combined oral contraceptive pills and breastfeeding. A factor associated with an increased risk of EOC was a family history of gynaecological cancer. Conclusions The results suggest that DMPA may have a protective effect against EOC. If this effect is real, then it represents an important non‐contraceptive benefit of DMPA. To evaluate the effect of depot medroxyprogesterone acetate (DMPA) in protecting against epithelial ovarian cancer (EOC) and to evaluate factors associated with the risk of EOC. A multicentre, case-control study. Twelve hospitals located across Thailand. Three hundred and thirty patients with EOC ('cases') and 982 matched controls were recruited from the 12 hospitals. Cases were newly diagnosed patients with EOC, demonstrated pathologically. Controls were age-matched patients admitted to different wards in the same hospital. Cases and controls were interviewed by trained interviewers using a standardised pre-tested questionnaire. The factors associated with EOC were evaluated using univariate and multivariate analyses. The odds ratio (OR) and 95% confidence interval (95% CI) were calculated to assess the relationship between DMPA and EOC. The use of DMPA was found to be associated with a 39% reduction in the risk of EOC with an OR of 0.61 and a 95% CI of 0.44-0.85 (P = 0.002). A significant risk reduction (83%) was observed when the duration of DMPA use was >3 years (OR 0.17; 95% CI 0.07-0.39; P < 0.001). Other factors associated with a reduced risk of EOC were the use of combined oral contraceptive pills and breastfeeding. A factor associated with an increased risk of EOC was a family history of gynaecological cancer. The results suggest that DMPA may have a protective effect against EOC. If this effect is real, then it represents an important non-contraceptive benefit of DMPA. |
| Author | Suraseranivong, V Wilailak, S Chotivanich, K Hamontri, S Bunyapipat, S Linasmita, V Lumbiganon, P Chindavijak, S Tanapat, Y Ittiwisavakul, K Kietpeerakool, C Thanapprapasr, D Vipupinyo, C Khemapech, N Therasakvichya, S Suekwattana, P |
| Author_xml | – sequence: 1 givenname: S surname: Wilailak fullname: Wilailak, S organization: Division of Gynaecologic Oncology, Department of Obstetrics and Gynaecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand – sequence: 2 givenname: C surname: Vipupinyo fullname: Vipupinyo, C organization: Department of Obstetrics and Gynaecology, Rajvithi Hospital, Bangkok, Thailand – sequence: 3 givenname: V surname: Suraseranivong fullname: Suraseranivong, V organization: Department of Obstetrics and Gynaecology, Bhumipol Hospital, Bangkok, Thailand – sequence: 4 givenname: K surname: Chotivanich fullname: Chotivanich, K organization: Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand – sequence: 5 givenname: C surname: Kietpeerakool fullname: Kietpeerakool, C organization: Department of Obstetrics and Gynaecology, Faculty of Medicine, Chiangmai University, Chiangmai, Thailand – sequence: 6 givenname: Y surname: Tanapat fullname: Tanapat, Y organization: Department of Obstetrics and Gynaecology Department, Phramongkutklao Hospital, Bangkok, Thailand – sequence: 7 givenname: S surname: Therasakvichya fullname: Therasakvichya, S organization: Department of Obstetrics and Gynaecology, Siriraj Hospital, Faculty of Medicine, Mahidol University, Bangkok, Thailand – sequence: 8 givenname: S surname: Hamontri fullname: Hamontri, S organization: Department of Obstetrics and Gynaecology, Faculty of Medicine, Srinakharinwirot University, Bangkok, Thailand – sequence: 9 givenname: V surname: Linasmita fullname: Linasmita, V organization: Division of Gynaecologic Oncology, Department of Obstetrics and Gynaecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand – sequence: 10 givenname: S surname: Bunyapipat fullname: Bunyapipat, S organization: Department of Obstetrics and Gynaecology, Faculty of Medicine, Prince of Songkla University, Songkla, Thailand – sequence: 11 givenname: S surname: Chindavijak fullname: Chindavijak, S organization: National Cancer Institute, Bangkok, Thailand – sequence: 12 givenname: K surname: Ittiwisavakul fullname: Ittiwisavakul, K organization: Maharaj Hospital, Nakhonratchasima, Thailand – sequence: 13 givenname: N surname: Khemapech fullname: Khemapech, N organization: Department of Obstetrics and Gynaecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand – sequence: 14 givenname: P surname: Suekwattana fullname: Suekwattana, P organization: Department of Obstetrics and Gynaecology, BMA Medical College and Vajira Hospital, Bangkok, Thailand – sequence: 15 givenname: D surname: Thanapprapasr fullname: Thanapprapasr, D organization: Division of Gynaecologic Oncology, Department of Obstetrics and Gynaecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand – sequence: 16 givenname: P surname: Lumbiganon fullname: Lumbiganon, P organization: Department of Obstetrics and Gynaecology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25783993$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22489761$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkU9v1DAQxS1URP_AV0C5IHFJsB1n7SBxgAJdUEsvoB6tiTMBL95kayew--2ZdJflii9-8rzn8fx8zk76oUfGMsELQevVqhBKi5xX0hSSC1nwUtam2D5iZ8fCyYPmOZXMKTtPacW5WEhePmGnUipT64U4Y_AeN8OYrbGNw3a3icN3TCNGapeBwxFG2vs2w40ff2DwELLhF0QPfeagdxhfZ5CtpzB6h_0YkU4T5m4gPYQsjVO7e8oedxASPjvsF-zbxw9fL5f59e3Vp8u317lTRpu85a4REppOqlZJ0zaug0qjdFCWdS1lJdBJ1fGuEYq0cFCVqqsl1FoJqXl5wV7u76Uh7ieawq59chgC9DhMyQouKl5XUkuymr3VxSGliJ3dRL-GuCOTnQHblZ052pmjnQHbB8B2S9Hnhy5TQ9COwb9EyfDiYIDkIHSRMPn0z1dpQ_OU5Huz9_32AXf__QD77vPtrCif7_Oe_mt7zEP8aRe61JW9-3Jlzc3NQi-X2t6VfwBm_ahw |
| CitedBy_id | crossref_primary_10_1016_j_jogc_2016_03_005 crossref_primary_10_1002_ijgo_14846 crossref_primary_10_2217_WHE_13_38 crossref_primary_10_1016_j_bpobgyn_2016_08_006 crossref_primary_10_1097_GME_0000000000001073 crossref_primary_10_1080_01635581_2020_1792948 crossref_primary_10_1097_AOG_0000000000003089 crossref_primary_10_7314_APJCP_2014_15_12_4829 crossref_primary_10_1007_s40273_019_00804_6 crossref_primary_10_1136_bmjsrh_2019_OOC crossref_primary_10_1186_s13053_022_00227_z crossref_primary_10_1016_j_contraception_2014_03_014 crossref_primary_10_1186_s40834_020_00142_5 crossref_primary_10_1007_s12325_017_0623_7 crossref_primary_10_1016_j_jogc_2015_12_003 crossref_primary_10_1016_j_celrep_2017_02_049 crossref_primary_10_1111_jmwh_12085 crossref_primary_10_1080_13625187_2020_1849617 crossref_primary_10_1002_ijgo_15567 crossref_primary_10_4236_ojog_2016_64024 crossref_primary_10_1093_humupd_dmac038 crossref_primary_10_1158_1055_9965_EPI_20_1355 crossref_primary_10_1177_0024363918811637 crossref_primary_10_1007_s13669_014_0106_7 crossref_primary_10_1080_13625187_2022_2054983 crossref_primary_10_1016_j_bpobgyn_2014_05_006 crossref_primary_10_1001_jamaoncol_2020_0421 crossref_primary_10_1016_j_ygyno_2022_01_014 crossref_primary_10_7314_APJCP_2014_15_24_10831 crossref_primary_10_1038_s41379_019_0370_1 crossref_primary_10_1186_s40834_023_00249_5 crossref_primary_10_1016_j_ygyno_2021_07_028 crossref_primary_10_4137_CMO_S32813 crossref_primary_10_1002_mc_23586 crossref_primary_10_1093_humupd_dmv023 crossref_primary_10_1111_apa_13102 crossref_primary_10_3390_curroncol29030172 crossref_primary_10_1016_j_annepidem_2021_04_006 |
| Cites_doi | 10.1002/ijc.2910620606 10.1016/0010-7824(94)90038-8 10.1001/jama.1983.03330360036032 10.1093/jnci/89.22.1726 10.2307/1965705 10.1111/j.1471-0528.2000.tb11106.x 10.1093/oxfordjournals.aje.a117055 10.1016/j.ygyno.2006.08.012 10.1016/j.contraception.2010.09.003 10.1016/S0140-6736(08)60167-1 10.1016/S0010-7824(00)00102-5 10.1093/oxfordjournals.aje.a113207 10.1001/jama.1982.03320480026020 10.1093/jnci/90.23.1774 10.1007/s10552-009-9440-x 10.1007/s10552-009-9450-8 |
| ContentType | Journal Article |
| Copyright | 2012 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2012 RCOG 2015 INIST-CNRS 2012 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2012 RCOG. |
| Copyright_xml | – notice: 2012 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2012 RCOG – notice: 2015 INIST-CNRS – notice: 2012 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2012 RCOG. |
| DBID | BSCLL IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
| DOI | 10.1111/j.1471-0528.2012.03298.x |
| DatabaseName | Istex Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-0528 |
| EndPage | 677 |
| ExternalDocumentID | 10_1111_j_1471_0528_2012_03298_x 22489761 25783993 BJO3298 ark_67375_WNG_8MM67HH7_W |
| Genre | article Multicenter Study Journal Article |
| GeographicLocations | Thailand |
| GeographicLocations_xml | – name: Thailand |
| GroupedDBID | --- --K .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1B1 1OB 1OC 1~5 23N 24P 33P 36B 3O- 3SF 4.4 4G. 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5RE 5VS 66C 6J9 6P2 6PF 7-5 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEDT AAESR AAEVG AAHHS AALRI AANLZ AAONW AAQFI AASGY AAWTL AAXRX AAXUO AAZKR ABCQN ABCUV ABEML ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACIUM ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADMUD ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DUUFO EBS EJD EMOBN EX3 F00 F01 F04 F5P FDB FEDTE FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NEJ NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIG RIWAO RJQFR ROL RPZ RWI RX1 SAMSI SEW SSZ SUPJJ TEORI V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 XIF XV2 ZXP ZY1 ~IA ~WT 08R AAJUZ AAPBV AAUGY AAVGM ABCVL ABHUG ABPTK ABWRO ACSMX ACXME ADAWD ADDAD AFVGU AGJLS AKALU IQODW CGR CUY CVF ECM EIF NPM AAMNL AAYXX CITATION 7X8 |
| ID | FETCH-LOGICAL-c4878-d0cb12abf24d428dbcfa57e2ca33992251ec24f0fb1451e1ca534f92a97412703 |
| IEDL.DBID | 33P |
| ISSN | 1470-0328 |
| IngestDate | Fri Aug 16 21:09:14 EDT 2024 Thu Nov 21 21:42:52 EST 2024 Sat Sep 28 08:34:06 EDT 2024 Sun Oct 22 16:07:14 EDT 2023 Sat Aug 24 00:40:38 EDT 2024 Wed Oct 30 09:58:09 EDT 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Ovarian diseases Ovary carcinoma Gynecology Medroxyprogesterone Malignant tumor Case control study Obstetrics Cancer Female genital diseases Progestagen |
| Language | English |
| License | CC BY 4.0 2012 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2012 RCOG. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4878-d0cb12abf24d428dbcfa57e2ca33992251ec24f0fb1451e1ca534f92a97412703 |
| Notes | ark:/67375/WNG-8MM67HH7-W istex:CE3630D05DEE15E16B1A9093476AE692F0B3655E ArticleID:BJO3298 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doi.org/10.1111/j.1471-0528.2012.03298.x |
| PMID | 22489761 |
| PQID | 1015095272 |
| PQPubID | 23479 |
| PageCount | 6 |
| ParticipantIDs | proquest_miscellaneous_1015095272 crossref_primary_10_1111_j_1471_0528_2012_03298_x pubmed_primary_22489761 pascalfrancis_primary_25783993 wiley_primary_10_1111_j_1471_0528_2012_03298_x_BJO3298 istex_primary_ark_67375_WNG_8MM67HH7_W |
| PublicationCentury | 2000 |
| PublicationDate | May 2012 |
| PublicationDateYYYYMMDD | 2012-05-01 |
| PublicationDate_xml | – month: 05 year: 2012 text: May 2012 |
| PublicationDecade | 2010 |
| PublicationPlace | Oxford, UK |
| PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: England |
| PublicationTitle | BJOG : an international journal of obstetrics and gynaecology |
| PublicationTitleAlternate | BJOG |
| PublicationYear | 2012 |
| Publisher | Blackwell Publishing Ltd Blackwell |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell |
| References | Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Lewis JL Jr, Strom BL, et al. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer. Am J Epidemiol 1994;139:654-61. Benjapibal MVP. Primary epithelial cancer and malignant germ cell tumor of ovary: A review of 368 cases. Thai J Obstet Gynaecol 2001;13:23-8. Hildreth NG, Kelsey JL, LiVolsi VA, Fischer DB, Holford TR, Mostow ED, et al. An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol 1981;114:398-405. Rosenberg L, Shapiro S, Slone D, Kaufman DW, Helmrich SP, Miettinen OS, et al. Epithelial ovarian cancer and combination oral contraceptives. JAMA 1982;247:3210-2. Depot-medroxyprogesterone acetate (DMPA) and risk of epithelial ovarian cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Cancer 1991;49: 191-5. Benjapibal MSI, Boriboonhiransarn D, Vichaidith P, Netphisuth A, Singto N. Primary ovarian tumors in postmenopausal women: a 10-year review. Siriraj Hosp Gaz 2000;52:307-12. Risch HA. Re: Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. J Natl Cancer Inst 1997;89:1726-7. Oral contraceptive use and the risk of ovarian cancer. The Centers for Disease Control Cancer and Steroid Hormone Study. JAMA 1983;249:1596-9. Lumbiganon P. Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary. Contraception 1994;49:203-9. Liskin L, Blackburn R. Hormonal contraception: new long-acting methods. Popul Rep K 1987;3:K57-87. Narkavonnakit T, Bennett T, Balakrishnan TR. Continuation of injectable contraceptives in Thailand. Stud Fam Plann 1982;13:99-105. Jordan SJ, Whiteman DC, Purdie DM, Green AC, Webb PM. Does smoking increase risk of ovarian cancer? A systematic review. Gynecol Oncol 2006;103:1122-9. Taneepanichskul S, Reinprayoon D, Phaosavadi S. DMPA use above the age of 35 in Thai women. Contraception 2000;61:281-2. Beral V, Doll R, Hermon C, Peto R, Reeves G. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 2008;371:303-14. Ramathibodi Cancer Registry. Annual report 1990-2001. Bangkook, Thailand: Ramathibodi Hospital, Mahidol University, 1-20. Purdie D, Green A, Bain C, Siskind V, Ward B, Hacker N, et al. Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group. Int J Cancer 1995;62:678-84. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al., editors. SEER Cancer Statistics Review, 1975-2008, Bethesda, MD: National Cancer Institute, Bethesda, MD, USA. Available from: http://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site, 2011. Olaitan A, Mocroft A, Jacobs I. Patterns in the incidence of age-related ovarian cancer in South East England 1967-1996. BJOG 2000;107:1094-6. Nanda K, Morrison CS, Kwok C, Byamugisha J, Jones L, Sriplienchan S, et al. Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda, Zimbabwe and Thailand. Contraception 2011;83:542-8. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998;90:1774-86. Titus-Ernstoff L, Rees JR, Terry KL, Cramer DW. Breast-feeding the last born child and risk of ovarian cancer. Cancer Causes Control 2010;21:201-7. Heintz AP, Odicino F, Maisonneuve P, Beller U, Benedet JL, Creasman WT, et al. Carcinoma of the ovary. J Epidemiol Biostat 2001;6:107-38. Jordan SJ, Siskind V, C Green A, Whiteman DC, Webb PM. Breastfeeding and risk of epithelial ovarian cancer. Cancer Causes Control 2010;21:109-16. Kaunitz AM. Injectable contraception: the USA perspective IPPF Med Bull 1992;26:1-3. 1983; 249 1982; 13 1995; 62 2010; 21 1987; 3 1991; 49 1994; 139 2007; IV 2001; 6 1981; 114 2000; 107 2000; 52 1997; 89 2011; 83 2000; 61 1998; 90 1982; 247 1994; 49 2004 1992; 26 2001; 13 2010; V 2008; 371 2006; 103 e_1_2_8_27_2 e_1_2_8_28_2 e_1_2_8_23_2 e_1_2_8_24_2 e_1_2_8_25_2 e_1_2_8_26_2 e_1_2_8_9_2 Benjapibal MVP (e_1_2_8_7_2) 2001; 13 e_1_2_8_21_2 Kaunitz AM (e_1_2_8_2_2) 1992; 26 e_1_2_8_22_2 Heintz AP (e_1_2_8_4_2) 2001; 6 Benjapibal MSI (e_1_2_8_8_2) 2000; 52 Srivatanakul P (e_1_2_8_19_2) 2007 e_1_2_8_16_2 e_1_2_8_17_2 Howlader N (e_1_2_8_18_2) e_1_2_8_13_2 (e_1_2_8_14_2) 1991; 49 e_1_2_8_15_2 Ramathibodi Cancer Registry (e_1_2_8_6_2) Sriplung H (e_1_2_8_5_2) 2004 Attasara P (e_1_2_8_20_2) 2010 (e_1_2_8_12_2) 1983; 249 Liskin L (e_1_2_8_3_2) 1987; 3 e_1_2_8_10_2 e_1_2_8_11_2 |
| References_xml | – volume: 21 start-page: 201 year: 2010 end-page: 7 article-title: Breast‐feeding the last born child and risk of ovarian cancer publication-title: Cancer Causes Control – volume: 103 start-page: 1122 year: 2006 end-page: 9 article-title: Does smoking increase risk of ovarian cancer? A systematic review publication-title: Gynecol Oncol – volume: 247 start-page: 3210 year: 1982 end-page: 2 article-title: Epithelial ovarian cancer and combination oral contraceptives publication-title: JAMA – volume: 62 start-page: 678 year: 1995 end-page: 84 article-title: Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case‐control study. Survey of Women’s Health Study Group publication-title: Int J Cancer – volume: 114 start-page: 398 year: 1981 end-page: 405 article-title: An epidemiologic study of epithelial carcinoma of the ovary publication-title: Am J Epidemiol – volume: 107 start-page: 1094 year: 2000 end-page: 6 article-title: Patterns in the incidence of age‐related ovarian cancer in South East England 1967–1996 publication-title: BJOG – volume: 139 start-page: 654 year: 1994 end-page: 61 article-title: A case–control study of oral contraceptive use and invasive epithelial ovarian cancer publication-title: Am J Epidemiol – volume: 21 start-page: 109 year: 2010 end-page: 16 article-title: Breastfeeding and risk of epithelial ovarian cancer publication-title: Cancer Causes Control – volume: 83 start-page: 542 year: 2011 end-page: 8 article-title: Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda, Zimbabwe and Thailand publication-title: Contraception – volume: 13 start-page: 99 year: 1982 end-page: 105 article-title: Continuation of injectable contraceptives in Thailand publication-title: Stud Fam Plann – volume: 90 start-page: 1774 year: 1998 end-page: 86 article-title: Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone publication-title: J Natl Cancer Inst – volume: IV start-page: 51 year: 2007 end-page: 3 – start-page: 1 end-page: 20 – start-page: 1 year: 2004 end-page: 161 – volume: 49 start-page: 203 year: 1994 end-page: 9 article-title: Depot‐medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary publication-title: Contraception – volume: 371 start-page: 303 year: 2008 end-page: 14 article-title: Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls publication-title: Lancet – volume: 52 start-page: 307 year: 2000 end-page: 12 article-title: Primary ovarian tumors in postmenopausal women: a 10‐year review publication-title: Siriraj Hosp Gaz – volume: V start-page: 3 year: 2010 end-page: 76 – volume: 89 start-page: 1726 year: 1997 end-page: 7 article-title: Re: Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer publication-title: J Natl Cancer Inst – volume: 61 start-page: 281 year: 2000 end-page: 2 article-title: DMPA use above the age of 35 in Thai women publication-title: Contraception – volume: 3 start-page: K57 year: 1987 end-page: 87 article-title: Hormonal contraception: new long‐acting methods publication-title: Popul Rep K – volume: 249 start-page: 1596 year: 1983 end-page: 9 article-title: Oral contraceptive use and the risk of ovarian cancer. The Centers for Disease Control Cancer and Steroid Hormone Study publication-title: JAMA – volume: 26 start-page: 1 year: 1992 end-page: 3 article-title: Injectable contraception: the USA perspective publication-title: IPPF Med Bull – volume: 13 start-page: 23 year: 2001 end-page: 8 article-title: Primary epithelial cancer and malignant germ cell tumor of ovary: A review of 368 cases publication-title: Thai J Obstet Gynaecol – volume: 6 start-page: 107 year: 2001 end-page: 38 article-title: Carcinoma of the ovary publication-title: J Epidemiol Biostat – volume: 49 start-page: 191 year: 1991 end-page: 5 article-title: Depot‐medroxyprogesterone acetate (DMPA) and risk of epithelial ovarian cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives publication-title: Int J Cancer – ident: e_1_2_8_9_2 doi: 10.1002/ijc.2910620606 – ident: e_1_2_8_24_2 doi: 10.1016/0010-7824(94)90038-8 – volume: 249 start-page: 1596 year: 1983 ident: e_1_2_8_12_2 article-title: Oral contraceptive use and the risk of ovarian cancer. The Centers for Disease Control Cancer and Steroid Hormone Study publication-title: JAMA doi: 10.1001/jama.1983.03330360036032 – volume: 52 start-page: 307 year: 2000 ident: e_1_2_8_8_2 article-title: Primary ovarian tumors in postmenopausal women: a 10‐year review publication-title: Siriraj Hosp Gaz contributor: fullname: Benjapibal MSI – ident: e_1_2_8_13_2 doi: 10.1093/jnci/89.22.1726 – ident: e_1_2_8_15_2 doi: 10.2307/1965705 – ident: e_1_2_8_17_2 doi: 10.1111/j.1471-0528.2000.tb11106.x – volume: 6 start-page: 107 year: 2001 ident: e_1_2_8_4_2 article-title: Carcinoma of the ovary publication-title: J Epidemiol Biostat contributor: fullname: Heintz AP – ident: e_1_2_8_22_2 doi: 10.1093/oxfordjournals.aje.a117055 – start-page: 3 volume-title: Cancer in Thailand 2001‐2003 year: 2010 ident: e_1_2_8_20_2 contributor: fullname: Attasara P – ident: e_1_2_8_28_2 doi: 10.1016/j.ygyno.2006.08.012 – ident: e_1_2_8_25_2 doi: 10.1016/j.contraception.2010.09.003 – volume: 3 start-page: K57 year: 1987 ident: e_1_2_8_3_2 article-title: Hormonal contraception: new long‐acting methods publication-title: Popul Rep K contributor: fullname: Liskin L – volume: 49 start-page: 191 year: 1991 ident: e_1_2_8_14_2 article-title: Depot‐medroxyprogesterone acetate (DMPA) and risk of epithelial ovarian cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives publication-title: Int J Cancer – volume: 26 start-page: 1 year: 1992 ident: e_1_2_8_2_2 article-title: Injectable contraception: the USA perspective publication-title: IPPF Med Bull contributor: fullname: Kaunitz AM – volume-title: SEER Cancer Statistics Review, 1975–2008 ident: e_1_2_8_18_2 contributor: fullname: Howlader N – start-page: 1 volume-title: Ministry of public health, Ministry of University Affairs, National Cancer Institute Report year: 2004 ident: e_1_2_8_5_2 contributor: fullname: Sriplung H – ident: e_1_2_8_23_2 doi: 10.1016/S0140-6736(08)60167-1 – volume: 13 start-page: 23 year: 2001 ident: e_1_2_8_7_2 article-title: Primary epithelial cancer and malignant germ cell tumor of ovary: A review of 368 cases publication-title: Thai J Obstet Gynaecol contributor: fullname: Benjapibal MVP – ident: e_1_2_8_16_2 doi: 10.1016/S0010-7824(00)00102-5 – ident: e_1_2_8_10_2 doi: 10.1093/oxfordjournals.aje.a113207 – start-page: 1 volume-title: Annual report 1990–2001 ident: e_1_2_8_6_2 contributor: fullname: Ramathibodi Cancer Registry – ident: e_1_2_8_11_2 doi: 10.1001/jama.1982.03320480026020 – ident: e_1_2_8_21_2 doi: 10.1093/jnci/90.23.1774 – ident: e_1_2_8_26_2 doi: 10.1007/s10552-009-9440-x – start-page: 51 volume-title: Cancer in Thailand 1998–2000 year: 2007 ident: e_1_2_8_19_2 contributor: fullname: Srivatanakul P – ident: e_1_2_8_27_2 doi: 10.1007/s10552-009-9450-8 |
| SSID | ssj0016203 |
| Score | 2.2930326 |
| Snippet | Please cite this paper as: Wilailak S, Vipupinyo C, Suraseranivong V, Chotivanich K, Kietpeerakool C, Tanapat Y, Therasakvichya S, Hamontri S, Linasmita V,... To evaluate the effect of depot medroxyprogesterone acetate (DMPA) in protecting against epithelial ovarian cancer (EOC) and to evaluate factors associated... Please cite this paper as: Wilailak S, Vipupinyo C, Suraseranivong V, Chotivanich K, Kietpeerakool C, Tanapat Y, Therasakvichya S, Hamontri S, Linasmita V,... OBJECTIVETo evaluate the effect of depot medroxyprogesterone acetate (DMPA) in protecting against epithelial ovarian cancer (EOC) and to evaluate factors... |
| SourceID | proquest crossref pubmed pascalfrancis wiley istex |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 672 |
| SubjectTerms | Biological and medical sciences Carcinoma, Ovarian Epithelial Case-Control Studies Contraceptive Agents, Female - administration & dosage Depot medroxyprogesterone acetate epithelial ovarian cancer Female Female genital diseases Gynecology. Andrology. Obstetrics Humans Medical sciences Medroxyprogesterone Acetate - administration & dosage Middle Aged Neoplasms, Glandular and Epithelial - epidemiology Neoplasms, Glandular and Epithelial - prevention & control Ovarian Neoplasms - epidemiology Ovarian Neoplasms - prevention & control Risk Factors Self Report Thailand - epidemiology Tumors |
| Title | Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case-control study |
| URI | https://api.istex.fr/ark:/67375/WNG-8MM67HH7-W/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1471-0528.2012.03298.x https://www.ncbi.nlm.nih.gov/pubmed/22489761 https://search.proquest.com/docview/1015095272 |
| Volume | 119 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwEB2VVkJcgLYUUqBypaq3VIljx0lvhX6sKm2pBKjcLMcfF1B2temiHvkP_MP-Emac3YVFPVRVT4ksTeTMeOL34ucxwJ6pEAeo2qZO1i4V3Fapqb1KhcqsywuRBUkbhQef1cW36viEyuScz_fC9PUhFj_cKDPi95oS3DTdf0mukApLHhVa_CAreF0dEJ5E0hB3cxSXiwWFksdDktEkS6mE3LKo584HLc1Ua-T0G1JOmg6dF_pTL-6CpcsoN05Tpy8e8wVfwvMZWGVH_ehahxXfbsDT4Ww5fhPsMcL3a4bdITEMSb1i3YVR65mxpGPEa-uYH9PGjx840tnoJ3Jz0zJLg21yyAyLisYoEfXY2vnbX79n8nkWS9--gq-nJ18-DtLZqQ2pRfJTpS6zTc5NE7hwyG1cY4ORynNrilgEV-bechGy0NAhwT63RhYi1Nwgs6Fl8GILVlvs6BtgIYTM4lPz0BjhSiQDrkDOKKQoKzTxCeTzCOlxX5xD_0tqVK7Je5q8p6P39E0C-zGUCwMz-U7iNiX11cWZrobDUg0GSl8lsLMU64UBfeQI1iWwOw--xpykhRbT-tG0I9kc4jDJFU_gdT8q_lpzUSEEzBMoY_Dv3XH94fwT3W0_1PAtPKPmXq35DlavJ1P_Hp50broTc-UPRJEQsw |
| link.rule.ids | 315,782,786,1408,27933,27934,46064,46488 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6VVgIuUJ5NS4uRELdUiWPHCbdCWwLtLkgUlZvl-HGhyla7XdQj_4F_2F_CjLO7sFUPCHFKFGUsZx7ON_bnMcBLUyEOULVNnaxdKritUlN7lQqVWZcXIguSNgo3n9Xwa7V_QGVyjuZ7Yfr6EIsJN4qMOF5TgNOE9LUoV5gLSx4pWnw3K3hd7SKgXBMl-iXt5yg-LZYUSh6PSUaZLKUicsu0nhtbWvpXrZHaL4k7aSaovtCfe3ETMF3GufFHdXj_v37iOtyb4VW21zvYA1jx3UO4PZityD8Cu48I_oJhf4gPQ2yvWHph1HlmLFEZ8do55s9p78cZOjsbfcf03HTMkr-NXzPDIqkxskQ9Pp34qx8_Zwx6FqvfPoYvhwcnb5t0dnBDajH_qVKX2Tbnpg1cOExvXGuDkcpza4pYB1fm3nIRstDSOcE-t0YWItTcYHJDK-HFE1jtsKMbwEIImcVW89Aa4UrMB1yBaaOQoqxQxCeQz02kz_v6HPrPvEblmrSnSXs6ak9fJvAq2nIhYMbfiN-mpD4dvtPVYFCqplH6NIGdJWMvBGicI2SXwIu59TWGJa21mM6PphNiziEUk1zxBJ72bvFbmosKUWCeQBmt_9cd128-fKS7zX8VfA53mpPBsT5-Pzzagrv0Sk_efAarF-Op34ZbEzfdiYHzC4bsFNs |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6VVqq4QMujhEcxEuKWKnHsOOEG3W6Xwi6VAJWb5fhxaZVd7XZRj_wH_iG_hBlnd2FRDwj1lCjKWM6Mx_4m83kM8NJUiANUbVMna5cKbqvU1F6lQmXW5YXIgqSNwoNPavS16h1RmZyT5V6Yrj7E6ocbeUacr8nBJy785eQKQ2HJI0OLH2QFr6sDxJNbAlE51dEvitNVRqHk8ZRklMlSqiG3zuq5tqW1pWqLtH5F1EkzQ-2F7tiL63DpOsyN61T_7k1-4Q7cWaBV9qYbXruw4dt7sD1c5OPvg-0hfr9k2B1iwxDXKxZeGLeeGUtERry2jvkJ7fy4wKHOxt8wODctszTapq-ZYZHSGDmiHp_O_M_vPxb8eRZr3z6AL_2jz4eDdHFsQ2ox-qlSl9km56YJXDgMblxjg5HKc2uKWAVX5t5yEbLQ0CnBPrdGFiLU3GBoQ3nw4iFsttjRR8BCCJnFVvPQGOFKjAZcgUGjkKKsUMQnkC8tpCdddQ79Z1Sjck3a06Q9HbWnrxJ4FU25EjDTc2K3KanPRse6Gg5LNRgofZbA_pqtVwI0yxGuS-DF0vganZIyLab14_mMeHMIxCRXPIG9blT8luaiQgyYJ1BG4_9zx_Xbk4909_h_BZ_D9mmvrz-8G71_ArfpjY65-RQ2L6dz_wxuzdx8P7rNLwe5E4E |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Depot+medroxyprogesterone+acetate+and+epithelial+ovarian+cancer%3A+a+multicentre+case%E2%80%93control+study&rft.jtitle=BJOG+%3A+an+international+journal+of+obstetrics+and+gynaecology&rft.au=Wilailak%2C+S&rft.au=Vipupinyo%2C+C&rft.au=Suraseranivong%2C+V&rft.au=Chotivanich%2C+K&rft.date=2012-05-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=1470-0328&rft.eissn=1471-0528&rft.volume=119&rft.issue=6&rft.spage=672&rft.epage=677&rft_id=info:doi/10.1111%2Fj.1471-0528.2012.03298.x&rft.externalDBID=10.1111%252Fj.1471-0528.2012.03298.x&rft.externalDocID=BJO3298 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1470-0328&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1470-0328&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1470-0328&client=summon |